NAVER has made an equity investment in healthcare corporations InBody, which holds the No. 1 global market share for body composition analyzers.
NAVER said on the 31st that it signed a global Digital Healthcare agreement with InBody on the 30th. NAVER plans to strengthen strategic cooperation to target the global healthcare market by investing about 32.5 billion won to secure 8.5% equity in InBody.
InBody sells professional and home body composition analyzers and automated blood pressure monitors to hospitals, fitness centers, schools and government offices, and general consumers. Along with body composition analyzers that rank No. 1 in global market share, the company is also diversifying its health management Digital Healthcare business by introducing the body composition data management platform "LB (LookInBody)."
InBody provides body composition testing products and services in 110 countries, based on 13 overseas subsidiaries in the United States, Japan, Europe, and India.
Choi In-hyuk, head of NAVER Tech Business, said, "By joining hands with InBody, the global No. 1 in body composition analysis, we plan to introduce to the global market data-driven, personalized health management services that seamlessly connect online and offline, as well as innovative healthcare services that combine AI and data."
He added, "We are planning services that identify diverse user needs, including senior care, dieting, and well-being, to provide personalized health management."